Coolisys Technologies Sees Increased Offshore Manufacturing Capacity and Higher Demand for Oxygen Concentrator and Ventilator Power Supplies
Fremont, CA, April 7, 2020 — Coolisys Technologies Corp. (“Coolisys”), is seeing offshore manufacturing partners, particularly in Asia, are back to near full capacity. In addition, Coolisys is realizing an increase in demand from its customers in the medical industry, specifically related to power supplies for oxygen concentrators and ventilators, with approximately $1.4 million in orders.
Our global supply chain was partially disrupted earlier this year by the COVID-19 outbreak in China and other Asian countries; however, based on improved conditions related to the COVID-19 pandemic in Asia, we have recently resumed the production of key products by Coolisys’ Chinese and Taiwanese manufacturing partners, including power applications for the medical industry.
Coolisys engineers have been designing and developing power supply products for the medical industry for over 12 years. Coolisys products have helped pave the way for advancements in a wide variety of medical applications, including surgical equipment, patient monitoring and therapy systems, patient beds and ventilators.
Coolisys products are designed to serve mission critical applications for lifesaving and life-sustaining applications across diverse markets. Coolisys medical power supplies meets IEC 60601-1 safety requirements for medical applied parts. Using power supplies that adhere r to the EN60601-1 safety standard helps medical device and system manufacturers speed compliance testing of their own products.
Coolisys’ CEO, Amos Kohn said, “In addition to recent defense industry orders, we are seeing an increase in demand for our products in the medical and healthcare sector. We are also pleased to report that our offshore manufacturing partners are back to near full capacity to enable us to continue our strong reputation for delivering custom high-reliability power solutions for the medical industry.”